Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 578-585

  Monso M ^a   De La Torre, B G ^a   Blanco, E ^b   Moreno, N ^b   Andreu, D ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES; T-CELLS; VACCINES; VIRUSES;

B CELLS; CELL EPITOPES; CONJUGATION CHEMISTRY; IMMUNE RESPONSE; IMMUNOGENICITY; MALEIMIDES; MULTIMERIC; SYNTHETIC VACCINES; T-CELL EPITOPES; THIOETHERS;

EPITOPES;

ANTIGEN; EPITOPE; PEPTIDE VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; T LYMPHOCYTE;

FOOT-AND-MOUTH DISEASE VIRUS; MUS; SUIDAE;

EID: 84876461419     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300515t     Document Type: Article

References (49)

1. Purcell, A. W., McCluskey, J., and Rossjohn, J. (2007) More than one reason to rethink the use of peptides in vaccine design Nat. Rev. Drug Discovery 6, 404-414
2. Patarroyo, M. E. and Patarroyo, M. A. (2008) Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines Acc. Chem. Res. 41, 377-386
3. Skwarczynski, M. and Toth, I. (2011) Peptide-based subunit nanovaccines Curr. Drug Delivery 8, 282-289
4. Van Regenmortel, M. H. V. and Muller, S. (1999) Synthetic peptides as antigens (Van der Vliet, P. C., Ed.) Elsevier, Amsterdam.
5. Tam, J. P. (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system Proc. Natl. Acad. Sci. U.S.A. 85, 5409-5413
6. Tam, J. P. (1996) Recent advances in multiple antigen peptides J. Immunol. Methods 196, 17-32
7. Sadler, K. and Tam, J. P. (2002) Peptide dendrimers: applications and synthesis J. Biotechnol. 90, 195-229
8. Rojo, J. (2009) Dendritic compounds as immune response modulators. New approaches for vaccine development Anti-infect. Agents Med. Chem. 8, 50-72
9. Cruz, L. J., Iglesias, E., Aguilar, J. C., Cabrales, A., Reyes, O., and Andreu, D. (2004) Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1 Bioconjugate Chem. 15, 1110-1117
10. Cruz, L. J., Iglesias, E., Aguilar, J. C., Gonzalez, L. J., Reyes, O., Albericio, F., and Andreu, D. (2004) A comparative study of different presentation strategies for an HIV peptide immunogen Bioconjugate Chem. 15, 112-120
11. Cubillos, C., de la Torre, B. G., Jakab, A., Clementi, G., Borras, E., Bárcena, J., Andreu, D., Sobrino, F., and Blanco, E. (2008) Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide J. Virol. 82, 7223-7230
12. Kowalczyk, W., de la Torre, B. G., and Andreu, D. (2010) Strategies and limitations in dendrimeric immunogen synthesis. The influenza virus M2e epitope as a case study Bioconjugate Chem. 21, 102-110
13. Kowalczyk, W., Monsó, M., de la Torre, B. G., and Andreu, D. (2010) Synthesis of multiple antigenic peptides (MAPs)-strategies and limitations J. Pept. Sci. 17, 247-251
14. Monsó, M., Tarradas, J., de la Torre, B. G., Sobrino, F., Ganges, L., and Andreu, D. (2011) Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes J. Pept. Sci. 17, 24-31
15. Lu, Y. A., Clavijo, P., Galantino, M., Shen, Z. Y., Liu, W., and Tam, J. P. (1991) Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system Mol. Immunol. 28, 623-630
16. Defoort, J. P., Nardelli, B., Huang, W., and Tam, J. P. (1992) A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity Int. J. Pept. Protein Res. 40, 214-221
17. Rose, K., Zeng, W., Brown, L. E., and Jackson, D. C. (1995) A synthetic peptide-based polyoxime vaccine construct of high purity and activity Mol. Immunol. 32, 1031-1037
18. Drijfhout, J. W. and Bloemhoff, W. (1991) A new synthetic functionalized antigen carrier Int. J. Pept. Protein Res. 37, 27-32
19. Schnolzer, M. and Kent, S. B. (1992) Constructing proteins by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease Science 256, 221-225
20. Rao, C. and Tam, J. P. (1994) Synthesis of peptide dendrimer J. Am. Chem. Soc. 116, 6975-6976
21. Spetzler, J. C. and Tam, J. P. (1995) Unprotected peptides as building blocks for branched peptides and peptide dendrimers Int. J. Pept. Protein Res. 45, 78-85
22. Fujita, Y., Moyle, P. M., Hieu, S., Simerska, P., and Toth, I. (2008) Investigation toward multi-epitope vaccine candidates using native chemical ligation Biopolymers 90, 624-632
23. Zeng, W., Ghosh, S., Macris, M., Pagnon, J., and Jackson, D. C. (2001) Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity Vaccine 19, 3843-3852
24. Monsó, M., Kowalczyk, W., Andreu, D., and de la Torre, B. G. (2012) Reverse thioether ligation route to multimeric peptide antigens Org. Biomol. Chem. 10, 3116-3121
25. Frisch, B., Boeckler, C., and Schuber, F. (1996) Synthesis of short polyoxyethylene-based heterobifunctional cross-linking reagents. Application to the coupling of peptides to liposomes Bioconjugate Chem. 7, 180-186
26. Schelte, P., Boeckler, C., Frisch, B., and Schuber, F. (2000) Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs Bioconjugate Chem. 11, 118-123
27. Wängler, C., Maschauer, S., Prante, O., Schäfer, M., Schirrmacher, R., Bartenstein, P., Eisenhut, M., and Wängler, B. (2010) Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties ChemBioChem 11, 2168-2181
28. Wängler, C., Moldenhauer, G., Eisenhut, M., Haberkorn, U., and Mier, W. (2008) Antibody-dendrimer conjugates: the number, not the size of the dendrimers, determines the immunoreactivity Bioconjugate Chem. 19, 813-820
29. Wängler, C., Wängler, B., Eisenhut, M., Haberkorn, U., and Mier, W. (2008) Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds Bioorg. Med. Chem. 16, 2606-2616
30. Zhu, J., Waengler, C., Lennox, R. B., and Schirrmacher, R. (2012) Preparation of water-soluble maleimide-functionalized 3 nm gold nanoparticles: a new bioconjugation yemplate Langmuir 28, 5508-5512
31. Houseman, B. T., Gawalt, E. S., and Mrksich, M. (2003) Maleimide-functionalized self-assembled monolayers for the preparation of peptide and carbohydrate biochips Langmuir 19, 1522-1531
32. Roberts, M. J., Bentley, M. D., and Harris, J. M. (2002) Chemistry for peptide and protein PEGylation Adv. Drug Delivery Rev. 54, 459-476
33. Veronese, F. M. (2001) Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22, 405-417
34. Sobrino, F. and Domingo, E. (2001) Foot-and-mouth disease in Europe EMBO Rep. 2, 459-461
35. Tarradas, J., Monsó, M., Muñoz, M., Rosell, R., Fraile, L., Frías, M. T., Domingo, M., Andreu, D., Sobrino, F., and Ganges, L. (2011) Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs Vaccine 29, 4422-4429
36. Li, G. X., Zhou, Y. J., Yu, H., Li, L., Wang, Y. X, Tong, W., Hou, J. W., Xu, Y. Z., Zhu, J. P., Xu, A. T., and Tong, G. Z. (2012) A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits Vet. Microbiol. 156, 200-204
37. Sadler, K., Zeng, W., and Jackson, D. C. (2002) Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation J. Pept. Res. 60, 150-158
38. Tam, J. P., Clavijo, P., Lu, Y. A., Nussenzweig, V., Nussenzweig, R., and Zavala, F. (1990) Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria J. Exp. Med. 171, 299-306
39. Blanco, E., Garcia-Briones, M., Sanz-Parra, A., Gomes, P., De Oliveira, E., Valero, M. L., Andreu, D., Ley, V., and Sobrino, F. (2001) Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus J. Virol. 75, 3164-3174
40. Sumption, K., Rweyemamu, M., and Wint, W. (2008) Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; combining expert opinion, official disease information and livestock populations to assist risk assessment Transbound. Emerg. Dis. 55, 5-13
41. Rweyemamu, M., Roeder, P., MacKay, D., Sumption, K., Brownlie, J., and Leforban, Y. (2008) Planning for the progressive control of foot-and-mouth disease worldwide Transbound. Emerg. Dis. 55, 73-87
42. Doel, T. R. (2003) FMD vaccines Virus Res. 91, 81-99
43. Sobrino, F., Saiz, M., Jimenez-Clavero, M. A., Nuñez, J. I., Rosas, M. F., Baranowski, E., and Ley, V. (2001) Foot-and-mouth disease virus: a long known virus, but a current threat Vet. Res. 32, 1-30
44. Zhang, L., Zhang, J., Chen, H. T., Zhou, J. H., Ma, L. N., Ding, Y. Z., and Liu, Y. S. (2011) Research in advance for FMD novel vaccines Virol. J. 8, 268
45. Becer, C. R., Hoogenboom, R., and Schubert, U. S. (2009) Click chemistry beyond metal-catalyzed cycloaddition Angew. Chem., Int. Ed. Engl. 48, 4900-4908
46. Bracci, L., Falciani, C., Lelli, B., Lozzi, L., Runci, Y., Pini, A., De Montis, M. G., Tagliamonte, A., and Neri, P. (2003) Synthetic peptides in the form of dendrimers become resistant to protease activity J. Biol. Chem. 47, 46590-46595
47. Falciani, C., Lozzi, L., Pini, A., Corti, F., Fabbrini, M., Bernini, A., Lelli, B., Niccolai, N., and Bracci, L. (2007) Molecular basis of branched peptides resistance to enzyme proteolysis Chem. Biol. Drug Des. 69, 216-221
48. Van Regenmortel, M. H. (2012) Basic research in HIV vaccinology is hampered by reductionist thinking Front. Immunol. 3, 194
49. Van Regenmortel, M. H. V (2007) The rational design of biological complexity: a deceptive metaphor Proteomics 7, 965-975